Toggle Main Menu Toggle Search

Open Access padlockePrints

The Newcastle University research output collection, currently available on ePrints, will shortly be moving to a new open repository platform, Figshare. To prepare for the data migration we have paused adding new content to ePrints, and will resume once the new repository is launched. During this time you will continue to have access to ePrints (but no new content will appear). We will share updates here when available.

Seladelpar (MBX-8025), a selective PPAR-δ agonist, in patients with primary biliary cholangitis with an inadequate response to ursodeoxycholic acid: a double-blind, randomised, placebo-controlled, phase 2, proof-of-concept study

Lookup NU author(s): Professor David Jones

Downloads

Licence

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (CC BY-NC-ND).

Publication metadata

Author(s): Jones DEJ, Boudes P, Swain M, Bowlus C, Galambos M, Bacon B, Doerffel Y, Gitlin N, Gordon S, Odin J, Sheridan D, Wörns M-A, Clark V, Corless L, Hartmann H, Jonas ME, Kremer A, Mells G, Buggisch P, Freilich B, Levy C, Vierling J, Bernstein D, Hartleb M, Janczewska E, Rochling F, Shah H, Shiffman M, Smith J, Choi Y-J, Steinberg A, Varga M, Chera H, Martin R, McWherter C, Hirschfield G

Publication type: Article

Publication status: Published

Journal: Lancet Gastroenterology and Hepatology

Year: 2017

Volume: 2

Issue: 10

Pages: 716-726

Print publication date: 01/10/2017

Online publication date: 14/08/2017

Acceptance date: 12/07/2017

Date deposited: 07/09/2017

ISSN (print): 2468-1253

ISSN (electronic): 2468-1156

Publisher: Elsevier

URL: https://doi.org/10.1016/S2468-1253(17)30246-7

DOI: 10.1016/S2468-1253(17)30246-7

Altmetrics

Altmetrics provided by Altmetric

Share